The Application of Systematic Review and Meta-analysis Concepts in Summarizing the Findings of Observational Studies

by Behzad Hajarizadeh, Behnam Sadeghirad, Ali-Akbar Haghdoost, Ali Mirzazadeh
Published 2007-12-01

Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners’ perspective

by Jack Wallace, Behzad Hajarizadeh, Jacqui Richmond, Stephen McNally
Published 2013-10-01

The Application of Systematic Review and Meta-analysis Concepts in Summarizing the Findings of Observational Studies

by Behzad Hajarizadeh, Behnam Sadeghirad, Ali-Akbar Haghdoost, Ali Mirzazadeh
Published 2007-12-01

Hepatitis B knowledge and associated factors among people with chronic hepatitis B

by Behzad Hajarizadeh, Jack Wallace, Jacqui Richmond, Naomi Ngo, Chris Enright
Published 2015-12-01

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia

by Mohammad T. Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore
Published 2022-07-01

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study

by Seyed Moayed Alavian, Mohammad Tasavon Gholamhoseini, Heidar Sharafi, Helena HL Borba, Asma Sabermahani, Behzad Hajarizadeh
Published 2022-06-01

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications.

by Jisoo A Kwon, Gregory J Dore, Behzad Hajarizadeh, Maryam Alavi, Heather Valerio, Jason Grebely, Rebecca Guy, Richard T Gray
Published 2021-01-01

Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012

by Maryam Alavi, Jason Grebely, Behzad Hajarizadeh, Janaki Amin, Sarah Larney, Matthew G. Law, Jacob George, Louisa Degenhardt, Gregory J. Dore
Published 2018-05-01

Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014)

by Reem Waziry, Jason Grebely, Janaki Amin, Maryam Alavi, Behzad Hajarizadeh, Jacob George, Gail V. Matthews, Matthew Law, Gregory J. Dore
Published 2017-10-01

Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia

by Jack Wallace, Yinzong Xiao, Jess Howell, Alex Thompson, Nicole Allard, Emily Adamson, Jacqui Richmond, Behzad Hajarizadeh, Melanie Eagle, Joseph Doyle, Margaret Hellard
Published 2022-03-01

Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions

by Jack Wallace, Jacqueline Richmond, Jessica Howell, Behzad Hajarizadeh, Jennifer Power, Carla Treloar, Peter A. Revill, Benjamin Cowie, Su Wang, Mark Stoové, Alisa Pedrana, Margaret Hellard
Published 2022-11-01

Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales

by Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, Gail V. Matthews, Marianne Martinello, Mark Danta, Janaki Amin, Matthew G. Law, Jacob George, Heather Valerio, Gregory J. Dore
Published 2022-10-01

High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study

by Jasmine Yee, Joanne M. Carson, Behzad Hajarizadeh, Joshua Hanson, James O’Beirne, David Iser, Phillip Read, Anne Balcomb, Joseph S. Doyle, Jane Davies, Marianne Martinello, Philiipa Marks, Gregory J. Dore, Gail V. Matthews, the REACH‐C Study Group
Published 2022-03-01

Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.

by Behzad Hajarizadeh, Bart Grady, Kimberly Page, Arthur Y Kim, Barbara H McGovern, Andrea L Cox, Thomas M Rice, Rachel Sacks-Davis, Julie Bruneau, Meghan Morris, Janaki Amin, Janke Schinkel, Tanya Applegate, Lisa Maher, Margaret Hellard, Andrew R Lloyd, Maria Prins, Gregory J Dore, Jason Grebely, InC3 Study Group
Published 2015-01-01

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

by Evan B. Cunningham, Behzad Hajarizadeh, Olav Dalgard, Janaki Amin, Margaret Hellard, Graham R Foster, Philip Bruggmann, Brian Conway, Markus Backmund, Geert Robaeys, Tracy Swan, Philippa S. Marks, Sophie Quiene, Tanya L Applegate, Martin Weltman, David Shaw, Adrian Dunlop, Julie Bruneau, Håvard Midgard, Stefan Bourgeois, Maria Christine Thurnheer, Gregory J Dore, Jason Grebely, on behalf of the ACTIVATE Study Group
Published 2017-06-01

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake amo...

by Anna Conway, Heather Valerio, Maryam Alavi, David Silk, Carla Treloar, Behzad Hajarizadeh, Alison D. Marshall, Marianne Martinello, Andrew Milat, Adrian Dunlop, Carolyn Murray, Bianca Prain, Charles Henderson, Janaki Amin, Phillip Read, Pip Marks, Louisa Degenhardt, Jeremy Hayllar, David Reid, Carla Gorton, Thao Lam, Michael Christmass, Alexandra Wade, Mark Montebello, Gregory J. Dore, Jason Grebely
Published 2022-07-01